1. Stats
  2. USPTO
  3. TC 1600
  4. Group 1650
  5. Art Unit 1652
  6. Examiner Ramirez

Examiner Ramirez Delia M

1652-RAMIREZ-DELIA-M

Employment Information

Art Unit:1652 — Chemistry: molecular biology and microbiology
Group:1650 — Enzymology, Microbiology, and Fermentation, Small Peptides and Bioacting Plant, Microbial and Animal Extracts
Classes: 435 — Chemistry: molecular biology and microbiology
424 — Drug, bio-affecting and body treating compositions
536 — Organic compounds -- part of the class 532-570 series
530 — Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
506 — Combinatorial chemistry technology: method, library, apparatus
198 — Conveyors: power-driven
510 — Cleaning compositions for solid surfaces, auxiliary compositions therefor, or processes of preparing the compositions
514 — Drug, bio-affecting and body treating compositions
426 — Food or edible material: processes, compositions, and products
800 — Multicellular living organisms and unmodified parts thereof and related processes
Phone:(571) 272-0938
Email:delia.ramirez@uspto.gov
Location:VA 22314
Title:Pat Examnr (Cbt-Biolgy)
Service:25 years
Grade:GS-14

Grant Rate and Difficulty Ranking

64
3-Year Grant rate: 68% over 379 cases
Difficulty: Harder
Difficulty Percentile: 64th

With Examiner Ramirez, you have a 68% chance of getting an issued patent by 3 years after the first office action. Examiner Ramirez is a harder examiner and in the 64th percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Ramirez, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1652

Examiner Ramirez's grant rate is lower than that of Art Unit 1652 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Ramirez 1.6
Art Unit 1652 1.6

Interview Benefit

Grant Rate without Interview

Examiner Ramirez has granted 185 of 286 cases without any applicant-requested interviews for a grant rate of 65%.

Grant Rate with Interview

Examiner Ramirez has granted 74 of 93 cases with at least one applicant-requested interview for a grant rate of 80%.

Interview Benefit

With Examiner Ramirez, conducting an interview increases your chance of getting a patent granted by 23%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
18100801 Functionalised Polsulphide Synthesis Method Rejection information available with a Premium Stats subscription. See our pricing. Abandoned View
18165191 Method For Producing Polyisoprenoid By Reaction Catalyzed By Mutant Cis-Prenyltransferase (Cpt) Family Protein, And Method For Producing Rubber Product Patented View
18293690 Viscous Polyhydroxyalkanoate, Preparation Thereof, And Use Thereof Patented View
18497106 Engineered Dnase Enzymes For Thrombosis Therapy Patented View
18487157 Novel Metalloproteases Abandoned View
18355170 Temperature-Sensitive Cas9 Protein Abandoned View
18461941 Nucleic Acids For Nuclease-Mediated Genome Editing Patented View
17919588 Genome Editing Using Cas9 Or Cas9 Variant Abandoned View
17997037 Parent Phytase Variant Patented View
18054142 Method For Purifying Indole-3-Lactic Acid From Lactobacillus Plantarum Fermentation Supernatant Patented View
17779561 Host Cells And Their Use For Producing Ribitol And Further Monosaccharides Patented View
18018561 Nitrilase Mutant And Use Thereof In Catalytic Synthesis Of 2-Chloronicotinic Acid Patented View
17323675 Recombinant Yeast Strains For Pentose Fermentation Abandoned View
18067421 Production Of Glycolate From Ethylene Glycol And Related Microbial Engineering Abandoned View
18957929 Novel Cas Effector Proteins, Gene Editing Systems, And Uses Thereof Patented View
18415827 L-Arginine-Glycine Amidinotransferase And Use Thereof In The Production Of Guanidinoacetic Acid Patented View
17631429 Modified Host Cells For High Efficiency Production Of Vanillin Patented View
17716624 Lipase Variants And The Use Thereof Patented View
17041258 Methods For Ethanol Production Using Engineered Yeast Abandoned View
18286832 Method For Increasing Productivity Of 2'-Fucosyllactose Through Changes In Culture Medium Composition And Culturing Abandoned View
16631969 Screening Method For Identification Of Neuroprotective Compounds Abandoned View
17294254 A Method For Processing Biomass Digestate Abandoned View
17269222 Enhanced Speed Polymerases For Sanger Sequencing Abandoned View
17873485 Methods Using Novel Cpf1 Mutations That Enhance The Dna Cleavage Activity Of Acidaminococcus Sp. Cpf1 Patented View
18628400 Dna Modifying Enzymes And Active Fragments And Variants Thereof And Methods Of Use Abandoned View
18171272 Polynucleotides Encoding Engineered Imine Reductases Patented View
16973270 Recombinant Host Cells And Methods For The Production Of Aspartic Acid And B-Alanine Abandoned View
17932420 Ketoreductase Polypeptides For The Reduction Of Acetophenones Patented View
17154826 Recombinant Crispr-Cas9 Nucleases With Altered Pam Specificity Abandoned View
17713015 Carbon Negative Production Of Diacids And Other Biochemicals Using Cell Free Biocatalysis Abandoned View
17851880 Dna Modifying Enzymes And Active Fragments And Variants Thereof And Methods Of Use Patented View
16758806 Methods For Rapidly Digesting Biopolymers With Ultrastable Enzymes For Mass Spectrometry-Based Analyses Patented View
17847313 Compositions And Methods For Production Of Salidroside, Icariside D2, And Precursors Of Salidroside And Icariside D2 Patented View
17251742 Methionine Analogue Synthesis Patented View
16860639 Delivery System For Functional Nucleases And Uses Thereof Abandoned View
18352037 Fusion Molecules Of Rationally-Designed Dna-Binding Proteins And Effector Domains Abandoned View
17293800 Improved Production Of Riboflavin Patented View
17131930 Enzymatic Cyclization Of Homofarnesylic Acid Abandoned View
17930595 Compositions Comprising A Crispr Nuclease And Uses Thereof Patented View
17833788 Biocatalysts And Methods For The Synthesis Of Armodafinil Patented View
18465727 Optimized Engineered Meganucleases Having Specificity For A Recognition Sequence In The Hepatitis B Virus Genome Abandoned View
18341669 Compositions And Methods For Producing High Secreted Yields Of Recombinant Proteins Patented View
18472881 Rationally-Designed Meganucleases With Altered Sequence Specificity And Dna-Binding Affinity Abandoned View
16982941 Zinc Finger Nucleases And Polynucleotide Encoding Said Nucleases Abandoned View
17885876 Gene Editing Systems Comprising An Rna Guide Targeting Stathmin 2 (Stmn2) And Uses Thereof Abandoned View
16760454 Cleaning Compositions Containing Dispersins Iii Patented View
17841082 Base Editing Enzymes Patented View
17745630 Genetically Engineered Cells Patented View
17768635 Mad7 Nuclease In Plants And Expanding Its Pam Recognition Capability Abandoned View
18468813 Genetically Engineered Strain Of Zymomonas Mobilis And Uses Thereof Abandoned View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.